您的购物车当前为空
FXIa-IN-9 (compound 3f) 是一种具有高选择性的FXIa抑制剂,通过与FXIa结合并形成氢键(human FXIaKi: 0.17 nM, rabbit FXIaKi: 0.5 nM),展现出显著的抗凝活性。该化合物在心房颤动、中风、心肌梗塞、深静脉血栓以及肺栓塞等血栓栓塞性疾病的研究中有潜在应用价值。

FXIa-IN-9 (compound 3f) 是一种具有高选择性的FXIa抑制剂,通过与FXIa结合并形成氢键(human FXIaKi: 0.17 nM, rabbit FXIaKi: 0.5 nM),展现出显著的抗凝活性。该化合物在心房颤动、中风、心肌梗塞、深静脉血栓以及肺栓塞等血栓栓塞性疾病的研究中有潜在应用价值。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 10-14周 | |
| 50 mg | ¥ 13,800 | 10-14周 | |
| 100 mg | ¥ 17,500 | 10-14周 |
FXIa-IN-9 相关产品
| 产品描述 | FXIa-IN-9 (compound 3f) is a potent, selective inhibitor of FXIa, demonstrating strong binding affinity through hydrogen bond formation (human FXIa K i : 0.17 nM, rabbit FXIa K i : 0.5 nM). It exhibits anticoagulant properties, making it valuable for research into thromboembolic conditions, including atrial fibrillation, stroke, myocardial infarction, deep vein thrombosis, and pulmonary embolism [1]. |
| 分子量 | 580.35 |
| 分子式 | C23H18Cl2F3N9O2 |
| CAS No. | 2816108-87-7 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容